These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15032116)

  • 21. Clinical course of the most common malignancies.
    Cruz J
    Med Sect Proc; 1989; ():81-93. PubMed ID: 2641558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cancer incidence in Japan].
    Tsukuma H; Ajiki W; Oshima A
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):840-6. PubMed ID: 15222098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII.
    Marugame T; Katanoda K
    Jpn J Clin Oncol; 2006 Jun; 36(6):399-400. PubMed ID: 16818481
    [No Abstract]   [Full Text] [Related]  

  • 24. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. StatBite: Breast cancer incidence in the U.S. and Italy.
    J Natl Cancer Inst; 2011 Jul; 103(13):1001. PubMed ID: 21737697
    [No Abstract]   [Full Text] [Related]  

  • 26. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In their own words. One man's mission against cancer.
    Bodai E
    Bull Am Coll Surg; 2001 Feb; 86(2):28-30. PubMed ID: 11351840
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
    Koro C; Barrett S; Qizilbash N
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer in Appalachia, 2001-2003.
    Wingo PA; Tucker TC; Jamison PM; Martin H; McLaughlin C; Bayakly R; Bolick-Aldrich S; Colsher P; Indian R; Knight K; Neloms S; Wilson R; Richards TB
    Cancer; 2008 Jan; 112(1):181-92. PubMed ID: 18000806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Skin tumours and primary multiple malignant neoplasms].
    Kudrina MI; Vinogradova NN; Kolen'ko NG; Zaev SN
    Klin Med (Mosk); 2009; 87(2):60-4. PubMed ID: 19348305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
    Vikram B
    J Natl Cancer Inst; 2006 Dec; 98(24):1826; author reply 1826. PubMed ID: 17179485
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies.
    Parekh DJ; Ankerst DP; Thompson IM
    J Natl Cancer Inst; 2007 Apr; 99(7):496-7. PubMed ID: 17405989
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolic syndrome is associated with reduced risk of prostate cancer.
    Tande AJ; Platz EA; Folsom AR
    Am J Epidemiol; 2006 Dec; 164(11):1094-102. PubMed ID: 16968859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The risk of cancer in the Netherlands].
    Kiemeney LA; Lemmers FA; Verhoeven RH; Aben KK; Honing C; de Nooijer J; Peeters PH; Visser O; Vlems FA
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2233-41. PubMed ID: 19009811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
    Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple primary cancers in patients with gastric cancer.
    Wu CW; Lo SS; Chen JH; Hsieh MC; Li AF; Lui WY
    Hepatogastroenterology; 2006; 53(69):463-7. PubMed ID: 16795993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid function and cancer risk: a prospective population study.
    Hellevik AI; Asvold BO; Bjøro T; Romundstad PR; Nilsen TI; Vatten LJ
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):570-4. PubMed ID: 19155436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
    Magee PJ; Rowland IR
    Br J Nutr; 2004 Apr; 91(4):513-31. PubMed ID: 15035679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of ecological regression in the study of colon, breast, ovary, non-Hodgkin's lymphoma, or prostate cancer and residential UV.
    Waltz P; Chodick G
    Eur J Cancer Prev; 2008 Jun; 17(3):279-86. PubMed ID: 18414201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.